Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-12

Clinical Trial Update: Clobetasol Propionate Versus Fractionated Carbon Dioxide Laser for the Treatment of Lichen Sclerosus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing clobetasol propionate to fractionated CO2 laser for vulvar lichen sclerosus completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBETASOL PROPIONATE (Clobetasol propionate)
  • Fractionated CO2 laser

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Vulvar Lichen Sclerosus | Phase 3 | Status: COMPLETED | Results posted: 2021-10-12